Biodexa Pharmaceuticals (BDRX) Treasury Shares (2019 - 2020)
Biodexa Pharmaceuticals (BDRX) reported Treasury Shares of $1.3 million for Q4 2020, down 10.81% on a YoY basis from $1.5 million in Q1 2020, and up 6.34% sequentially from $1.2 million in Q2 2020.
Biodexa Pharmaceuticals (BDRX) Treasury Shares (2019 - 2020) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 2 years of Treasury Shares data on file, last reported at $1.3 million in Q4 2020.
- For the quarter ending Q4 2020, Treasury Shares fell 10.81% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2020 stood at $1.3 million (down 10.81% YoY), and the FY2020 full-year result was $1.3 million, down 12.66% from the prior year.
- Treasury Shares climbed to $1.3 million in Q4 2020, from $1.2 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.5 million in Q4 2019 to a low of $1.2 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.32 Mn |
| Dec 31, 2020 | 1.32 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Jun 30, 2020 | 1.24 Mn |
| Dec 31, 2019 | 1.48 Mn |
| Dec 31, 2019 | 1.48 Mn |